Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Non-Tech : The Critical Investing Workshop -- Ignore unavailable to you. Want to Upgrade?

To: Jim Willie CB who wrote (7460)	3/14/2000 4:51:00 PM
From: r.edwards	Read Replies (1) \| Respond to of 35685

FDA, Clinton what a bunch of caca!, the bastards banned breast implants when i owned a mgf. of such. These people on cnbc gotta go,,,,,,,,give them something besides GE, its good but give them more of a stake, then they wouldn't jawbone forever on the negative. Oh well made money on sandisk..............

To: Jim Willie CB who wrote (7460)	3/14/2000 5:15:00 PM
From: SecularBull	Read Replies (1) \| Respond to of 35685

It's not a copyright. It's a patent, and many have already been issued. LoF

To: Jim Willie CB who wrote (7460)	3/15/2000 2:13:00 AM
From: Dr. David Gleitman	Read Replies (2) \| Respond to of 35685

Good morning JW: Re: Copyrights. It is my understanding that Bill Gates has sued anderson windows for their use of the word "windows", claiming that windows is proprietary. In addition, Bill Gates is also claiming that the numbers 1 and 0 are also proprietary and belong to the microsoft domain. Re biotechs, my concern has always been that in this era of cost containment (read: rationing of healthcare resources), no private or goverernmental agency is going to stand by and watch private industry get rich off their backs. The cost of drugs appear to be one of the greatest sources of escalating health care costs. God only knows it's no longer from doctor's fees. I'll be the first to attest to that! Therefore, I fail to understand where the pot of gold is going to be at the end of the rainbow. It is also a fact that if biotech companies have employed the data or recourses of governmental financed data, the gov't will want a piece of the action. I've seen this happen with Myriad Genetics (MYGN). David